1. Business model and intended use
Polaris Research (trading as Polaris Research, ABN 64609459416) supplies lyophilised reference materials and laboratory reagents to qualified purchasers in Australia for lawful in-vitro and laboratory research use only.
Our catalogue is not offered for human or veterinary consumption, injection, self-administration, cosmetic use, performance enhancement, weight loss, anti-ageing, or any therapeutic, diagnostic, or preventive purpose.
Products are not listed on the Australian Register of Therapeutic Goods (ARTG) and are not represented, marketed, or sold as medicines, supplements, cosmetics, or consumer wellness products.
2. Lawful research-supply position
We operate as a research-material supplier. Product pages, checkout, order confirmations, and customer support describe identity, purity, analytical testing, storage, and research context only.
We do not make therapeutic claims, dosing guidance, administration instructions, or outcome promises. Support staff are instructed to decline requests for human-use or protocol advice.
Every first-time purchaser must complete a versioned research-use acknowledgement (`research-use-v1`) before order placement. The acknowledgement is stored against the verified email and snapshotted onto each order.
3. Quality, traceability, and documentation
Each batch is independently tested where applicable. Batch-specific documentation (Certificate of Analysis) is issued from accredited third-party laboratories and can be verified online.
Transactional records include SKU, batch references, and research-use attestation metadata to support traceability and compliance review.
4. Advertising and destination compliance
Brand search campaigns for Polaris Research land on a policy-compliant research-supply page that does not name restricted compounds in ad destinations.
We maintain this public certification, our Research-Use Policy, Compliance hub, and related legal pages for policy reviewers and certification teams.
We request certification under Google's healthcare and medicines programme as a laboratory research-material supplier serving Australia, consistent with our research-only business model.
5. Declaration
I declare that the statements in this certification are true and accurate as at 1 July 2026, and that Polaris Research supplies materials exclusively for lawful laboratory and in-vitro research use in accordance with the policies published at https://polarisresearch.com.au.
Authorised Signatory
Authorised Representative
Polaris Research — Compliance
compliance@polarisresearch.com.au
This document is published for policy and certification review. It does not replace statutory licences where those apply. For related policies see Research-Use Policy, Compliance, and Terms of Service.